The director of the Centers for Disease Control and Prevention (CDC) told Congress Friday that he was not directly involved in the Trump administration’s decision to order hospitals to stop sending COVID-19 data directly. at the agency.
The administration earlier this month told hospitals to start reporting hospitalization and data testing to a new Health and Human Services database managed by a private contractor, bypassing the CDC.
“We weren’t directly involved in the final decision, but what I can say is this: CDC then and now still has access to all the data, it does all the analytical data, so there’s no restriction on any of the data. said director Robert. Redfield told the House Select Subcommittee on the response to Coronavirus.
Rep. Aigües MaxinesMaxine Moore Waters Night Defense: Pompey pressured the movement to withdraw troops from Germany The panel abruptly escapes the confirmation hearing | Trump finds a family of Senate soldiers killed in the Senate group’s rejection of the confirmation hearing for a controversial candidate at the Pentagon at the last minute Defense overnight: the guard who will testify that the compensation of the square of Lafayette was an “unprovoked climb” | Dems pressures the withdrawal of the controversial Pentagon candidate Watchdog says Pentagon does not consider climate change risks for MORE contractors grilled CDC director Redfield over administrator Trump’s hospital data decision to evade his department pic.twitter.com/eScqtT2QNb
– NowThis (@nowthisnews) July 31, 2020
Redfield, who was questioned by Rep. Maxine Waters (D-Calif.) Said she was told of the change after the decision by the Department of Health and Human Services (HHS), the parent agency of the CDC.
He also said he has not discussed the decision with HHS Secretary Alex Azar or Vice President Pence, who has led the administration’s COVID-19 response.
Redfield said the goal of the change was to improve access to real-time hospitalization data so that the administration can have a better idea of where to send remdesivir, a drug that has been shown to treat the COVID-19.
“I think the reason changes were made was to ensure that people could access a counter in a timely manner,” Redfield said.
Some public health experts criticized the change that the administration is concerned is slowing the CDC in its coronavirus response.